Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-020857
Filing Date
2025-02-05
Accepted
2025-02-05 16:39:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d919530d424b3.htm 424B3 375749
2 GRAPHIC g919530g03l58.jpg GRAPHIC 40132
  Complete submission text file 0001193125-25-020857.txt   432239
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-284606 | Film No.: 25593919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)